Epidemiology of Invasive Fungal Disease in Children

Zoi Dorothea Pana, Emmanuel Roilides, Adilia Warris, Andreas H. Groll, Theoklis Zaoutis

Research output: Contribution to journalArticle

2 Citations (Scopus)
3 Downloads (Pure)

Abstract

Considerable progress has been made in the prevention, diagnosis, and management of pediatric patients with invasive fungal disease (IFD). The reported decreasing trend in the incidence of invasive candidiasis (IC) over the past 15 years in both neonates and children has been encouraging. Nevertheless, due to the growing number of immunocompromised children at risk for IFD, this disease continues to be associated with significant morbidity and death and with increased financial burden to the health care system. Therefore, it is important to understand the contemporary epidemiology of IFD. Incidence rates of IFD in children are affected by geographical, population, and time variability. There is an ongoing effort to constantly document and update the incidence of IFD and species distribution among different pediatric populations as a means to direct preventative, diagnostic, and therapeutic resources to the most appropriate subset of patients. Children with a hematologic malignancy or a primary or secondary immunodeficiency, those undergoing solid organ or hematopoietic stem cell transplantation, and premature neonates are the major subsets of pediatric patients at risk of developing IFD. In this review, we focus on fungal disease epidemiology with a specific emphasis on the 2 most common pediatric IFDs, IC and invasive aspergillosis (IA).

Original languageEnglish
Pages (from-to)S3-S11
Number of pages9
JournalJournal of the Pediatric Infectious Diseases Society
Volume6
Issue numbersuppl_1
Early online date30 Aug 2017
DOIs
Publication statusPublished - 1 Sep 2017

Fingerprint

Mycoses
Epidemiology
Invasive Candidiasis
Pediatrics
Incidence
Newborn Infant
Aspergillosis
Hematopoietic Stem Cell Transplantation
Hematologic Neoplasms
Population
Morbidity
Delivery of Health Care

Keywords

  • epidemiology
  • invasive aspergillosis
  • invasive candidiasis
  • invasive fungal disease
  • pediatric patients

Cite this

Pana, Z. D., Roilides, E., Warris, A., Groll, A. H., & Zaoutis, T. (2017). Epidemiology of Invasive Fungal Disease in Children. Journal of the Pediatric Infectious Diseases Society, 6(suppl_1), S3-S11. https://doi.org/10.1093/jpids/pix046

Epidemiology of Invasive Fungal Disease in Children. / Pana, Zoi Dorothea; Roilides, Emmanuel; Warris, Adilia; Groll, Andreas H.; Zaoutis, Theoklis.

In: Journal of the Pediatric Infectious Diseases Society, Vol. 6, No. suppl_1, 01.09.2017, p. S3-S11.

Research output: Contribution to journalArticle

Pana, ZD, Roilides, E, Warris, A, Groll, AH & Zaoutis, T 2017, 'Epidemiology of Invasive Fungal Disease in Children', Journal of the Pediatric Infectious Diseases Society, vol. 6, no. suppl_1, pp. S3-S11. https://doi.org/10.1093/jpids/pix046
Pana, Zoi Dorothea ; Roilides, Emmanuel ; Warris, Adilia ; Groll, Andreas H. ; Zaoutis, Theoklis. / Epidemiology of Invasive Fungal Disease in Children. In: Journal of the Pediatric Infectious Diseases Society. 2017 ; Vol. 6, No. suppl_1. pp. S3-S11.
@article{249d0fc0365a40ebb26035ee9006d439,
title = "Epidemiology of Invasive Fungal Disease in Children",
abstract = "Considerable progress has been made in the prevention, diagnosis, and management of pediatric patients with invasive fungal disease (IFD). The reported decreasing trend in the incidence of invasive candidiasis (IC) over the past 15 years in both neonates and children has been encouraging. Nevertheless, due to the growing number of immunocompromised children at risk for IFD, this disease continues to be associated with significant morbidity and death and with increased financial burden to the health care system. Therefore, it is important to understand the contemporary epidemiology of IFD. Incidence rates of IFD in children are affected by geographical, population, and time variability. There is an ongoing effort to constantly document and update the incidence of IFD and species distribution among different pediatric populations as a means to direct preventative, diagnostic, and therapeutic resources to the most appropriate subset of patients. Children with a hematologic malignancy or a primary or secondary immunodeficiency, those undergoing solid organ or hematopoietic stem cell transplantation, and premature neonates are the major subsets of pediatric patients at risk of developing IFD. In this review, we focus on fungal disease epidemiology with a specific emphasis on the 2 most common pediatric IFDs, IC and invasive aspergillosis (IA).",
keywords = "epidemiology, invasive aspergillosis, invasive candidiasis, invasive fungal disease, pediatric patients",
author = "Pana, {Zoi Dorothea} and Emmanuel Roilides and Adilia Warris and Groll, {Andreas H.} and Theoklis Zaoutis",
note = "Financial support. A.W. is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology at University of Aberdeen (grant MR/N006364/1). Supplement sponsorship. This article appears as part of the supplement “State of the Art Diagnosis of Pediatric Invasive Fungal Disease: Recommendations From the Joint European Organization for the Treatment of Cancer/Mycoses Study Group (EORTC/MSG) Pediatric Committee,” sponsored by Astellas.",
year = "2017",
month = "9",
day = "1",
doi = "10.1093/jpids/pix046",
language = "English",
volume = "6",
pages = "S3--S11",
journal = "Journal of the Pediatric Infectious Diseases Society",
issn = "2048-7193",
publisher = "Oxford University Press",
number = "suppl_1",

}

TY - JOUR

T1 - Epidemiology of Invasive Fungal Disease in Children

AU - Pana, Zoi Dorothea

AU - Roilides, Emmanuel

AU - Warris, Adilia

AU - Groll, Andreas H.

AU - Zaoutis, Theoklis

N1 - Financial support. A.W. is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology at University of Aberdeen (grant MR/N006364/1). Supplement sponsorship. This article appears as part of the supplement “State of the Art Diagnosis of Pediatric Invasive Fungal Disease: Recommendations From the Joint European Organization for the Treatment of Cancer/Mycoses Study Group (EORTC/MSG) Pediatric Committee,” sponsored by Astellas.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Considerable progress has been made in the prevention, diagnosis, and management of pediatric patients with invasive fungal disease (IFD). The reported decreasing trend in the incidence of invasive candidiasis (IC) over the past 15 years in both neonates and children has been encouraging. Nevertheless, due to the growing number of immunocompromised children at risk for IFD, this disease continues to be associated with significant morbidity and death and with increased financial burden to the health care system. Therefore, it is important to understand the contemporary epidemiology of IFD. Incidence rates of IFD in children are affected by geographical, population, and time variability. There is an ongoing effort to constantly document and update the incidence of IFD and species distribution among different pediatric populations as a means to direct preventative, diagnostic, and therapeutic resources to the most appropriate subset of patients. Children with a hematologic malignancy or a primary or secondary immunodeficiency, those undergoing solid organ or hematopoietic stem cell transplantation, and premature neonates are the major subsets of pediatric patients at risk of developing IFD. In this review, we focus on fungal disease epidemiology with a specific emphasis on the 2 most common pediatric IFDs, IC and invasive aspergillosis (IA).

AB - Considerable progress has been made in the prevention, diagnosis, and management of pediatric patients with invasive fungal disease (IFD). The reported decreasing trend in the incidence of invasive candidiasis (IC) over the past 15 years in both neonates and children has been encouraging. Nevertheless, due to the growing number of immunocompromised children at risk for IFD, this disease continues to be associated with significant morbidity and death and with increased financial burden to the health care system. Therefore, it is important to understand the contemporary epidemiology of IFD. Incidence rates of IFD in children are affected by geographical, population, and time variability. There is an ongoing effort to constantly document and update the incidence of IFD and species distribution among different pediatric populations as a means to direct preventative, diagnostic, and therapeutic resources to the most appropriate subset of patients. Children with a hematologic malignancy or a primary or secondary immunodeficiency, those undergoing solid organ or hematopoietic stem cell transplantation, and premature neonates are the major subsets of pediatric patients at risk of developing IFD. In this review, we focus on fungal disease epidemiology with a specific emphasis on the 2 most common pediatric IFDs, IC and invasive aspergillosis (IA).

KW - epidemiology

KW - invasive aspergillosis

KW - invasive candidiasis

KW - invasive fungal disease

KW - pediatric patients

U2 - 10.1093/jpids/pix046

DO - 10.1093/jpids/pix046

M3 - Article

C2 - 28927200

VL - 6

SP - S3-S11

JO - Journal of the Pediatric Infectious Diseases Society

JF - Journal of the Pediatric Infectious Diseases Society

SN - 2048-7193

IS - suppl_1

ER -